Janet R. Vos

Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype

Judith E. Grolleman, Richarda M. de Voer, Fadwa A. Elsayed et al. · Cancer Cell · 2019 · 166 citations · Full text

Tumor Biology, Multi-tumor Phenotype, Somatic Variant +11

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 68 citations · Full text

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome

Linda A.J. Hendricks, Nicoline Hoogerbrugge, Arjen R. Mensenkamp et al. · JNCI Journal of the National Cancer Institute · 2022 · 45 citations · Full text

Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Steven Laurie, Kiran Polavarapu, Nika Schuermans et al. · Nature Medicine · 2025 · 29 citations · Full text

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome

Janet R. Vos, Ingrid E. Fakkert, Liesbeth Spruijt et al. · International Journal of Cancer · 2020 · 27 citations · Full text

Genome Instability, Lynch Syndrome, Oncology +14